NEW YORK, Aug. 23, 2024 /PRNewswire/ -- The global echocardiography (ECG) devices market size is estimated to grow by USD 5.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 6.78% during the forecast period. Increased incidence of cardiac disorders is driving market growth, with a trend towards integration of technologies to develop advanced ECG devices. However, high cost of ecg products and procedures poses a challenge. Key market players include AliveCor Inc., Allengers Medical Systems Ltd., Baxter International Inc., Bionet Co. Ltd., Biotricity Inc., Bittium Corp., Cardinal Health Inc., DMS Service LLC, Fukuda Denshi Co. Ltd, General Electric Co., Halma Plc, iRhythm Technologies Inc., Johnson and Johnson Services Inc., Koninklijke Philips N.V., Medtronic Plc, Nasiff Associates Inc., NEXUS LIFECARE PVT. LTD., Nihon Kohden Corp., Norav Medical, OSI Systems Inc., SCHILLER AG, and QT Medical.
Continue Reading
Technavio has announced its latest market research report titled Global echocardiography (ECG) devices market 2024-2028
Get a detailed analysis on regions, market segments, customer landscape, and companies -
Click for the snapshot of this report
Key Market Trends Fueling Growth
The ECG devices market has experienced significant growth due to the introduction of advanced technologies in cardiovascular disease (CVD) testing. New monitoring technologies have improved disease diagnosis and treatment, allowing for more flexibility and portability in ECG systems. Companies are incorporating sophisticated technologies to enhance workflow, such as wireless data systems that enable physicians to place workstations in convenient locations during patient exercises. For instance, QT Medical's PCA 500 received FDA clearance in October 2022 for use in all pediatric populations, expanding its reach to newborns, infants, children, and adolescents. Continuous digitization of record systems has led vendors to improve data connectivity for various management solutions, offering wide access and interoperability with other software systems and cloud and smartphone access. Leading vendors focus on providing ECG devices with proven clinical excellence and enhanced applications, such as GE Healthcare's CASE exercise testing system, which offers quick and easy access to cardiac function during exercise for better diagnostic confidence. The ongoing technological advances in ECG devices and their integration with compatible technologies will positively impact the market growth of ECG devices globally during the forecast period.
The Echocardiography market is experiencing significant growth due to the rising prevalence of cardiovascular diseases, including blood clots, heart valve disease, heart failure, pericardial disease, and coronary heart disease. Echocardiography devices, which use ultrasonic sound waves to examine the heart's chambers, valves, and function, are essential diagnostic tools for heart-related disorders such as heart arrhythmias, atrial fibrillation, and heart diseases. Technological developments in this field include AI-driven auto-measure applications, neural network-based algorithms, and workflow optimization. Companies like Clarius Mobile Health and Ultrasound Workspace are leading the way with innovative products like the Clarius C3 and Ultrasound Workspace, respectively. Transthoracic and transesophageal echocardiography, as well as stress echocardiography and Doppler imaging, are popular diagnostic procedures. Devices like the Vivid Ultra Edition and Ultrasound 3300 offer measurement uniformity, rapid diagnosis, and diagnostic test time efficiency. The Heart Center Leipzig is also making strides in the field with advancements in echocardiography technology. Product innovation continues to drive the market, with a focus on noninvasive diagnostic procedures and efficiency. The vaccination against uncontrolled hypertension and angioplasty surgeries are also contributing factors. Overall, the echocardiography market is expected to grow as the demand for accurate and efficient heart diagnostic tools increases.Discover a Comprehensive 360° Market Analysis: Understand the Impact of AI. For detailed information-
Request Sample!
Market Challenges
The ECG devices market is facing challenges due to increasing pressure on hospitals, diagnostic centers, and ambulatory surgical centers (ASCs) to manage capital investments. This pressure has resulted in a decrease in investments in advanced ECG devices, such as wearable devices with treadmill and advanced software installations, which are more expensive than portable and handheld ECG devices. The average cost of an ECG device in the US is USD1,750, but prices can vary greatly, ranging from USD550 to USD3,300. Tier-1 and Tier-2 hospitals are the primary buyers of these devices, limiting their use in homecare settings and small testing laboratories. Companies like Hill-Rom, Schiller, GE Healthcare, Philips Healthcare, and Nihon Koden offer 12-lead ECG devices, while DailyCare BioMedical, AliveCor, Cardiac Designs, and REKA Health provide one to three lead devices with integrated displays, costing between USD25 to USD500. However, individual-focused diagnostics for chronic cardiac conditions can increase costs further. These factors may hinder the growth of the ECG devices market during the forecast period.
The Echocardiography (ECG) devices market faces challenges in diagnosing various heart conditions such as heart failure, pericardial disease, and coronary heart disease. Traditional methods like transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are widely used for heart function assessment. However, technological developments in echocardiography, like Doppler imaging and stress echocardiography, offer more accurate and efficient diagnostic tests. Companies like Clarius Mobile Health and Ultrasound Workspace are innovating with handheld and portable devices, making noninvasive diagnostic procedures more accessible. New products like the Vivid Ultra Edition and Ultrasound 3300 from General Imaging and Cardiovascular Imaging offer measurement uniformity and workflow optimization. Challenges remain in managing uncontrolled hypertension and ensuring diagnostic test time efficiency. Technological advancements, such as AI-driven and neural network-based algorithms, can help with rapid diagnosis and improving 2D echo imaging quality. The Heart Center Leipzig is a leading institution in echocardiography research and innovation, pushing the boundaries of this essential diagnostic tool.
For more insights on driver and challenges -
Download a Sample Report
Segment Overview
This echocardiography (ecg) devices market report extensively covers market segmentation by
End-user
1.1 Hospitals
1.2 Diagnostic centers
Product
2.1 Resting
2.2 Ambulatory
2.3 Stress
Geography
3.1 North America
3.2 Europe
3.3 Asia
3.4 Rest of World (ROW)
1.1 Hospitals- The identification and diagnosis of cardiomyopathies, such as dilated and hypertrophic, through echocardiography are driving market growth. Echocardiography's non-invasive nature and lack of known risks make it a preferred choice for heart disease symptoms. Diagnostic centers are acquiring these devices due to the absence of ECG equipment in some hospitals. However, cost pressure from governments to reduce healthcare expenses is leading to increased usage of traditional ECG devices. Advanced ECG products, like wearable devices, face challenges due to this trend. Technological advancements and device integrations will positively impact the market, benefiting diagnostic centers in the global ECG devices market.For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 - 2022) -
Download a Sample Report
Research Analysis
Echocardiography, also known as an ECG (Electrocardiogram) ultrasound, is a noninvasive diagnostic procedure used to assess heart function and structure. It employs ultrasonic sound waves to visualize the heart's chambers, valves, and blood flow. This technique plays a crucial role in diagnosing conditions such as cardiovascular disease, blood clots, atrial fibrillation, and uncontrolled hypertension. Two common types include transthoracic and transesophageal echocardiography. The Global echocardiography market is experiencing significant growth due to technological developments and increasing demand for noninvasive diagnostic procedures. Institutions like the British Heart Foundation and medical centers such as Heart Center Leipzig and Saarland University Hospital are at the forefront of research and innovation. Devices like General Imaging's Ultrasound 3300 offer improved efficiency and workflow optimization. Echocardiography is essential for assessing heart health, enabling early detection and effective treatment.
Market Research Overview
The Echocardiography market encompasses noninvasive diagnostic procedures used for assessing various heart conditions, including cardiovascular disease, blood clots, heart's chambers, valves, heart diseases, heart arrhythmias, heart valve disease, heart failure, pericardial disease, coronary heart disease, and angioplasty surgeries. This market leverages ultrasound technology, with Transthoracic and Transesophageal echocardiography being the most common techniques. Advancements in this field include Doppler imaging, AI-driven auto-measure applications, and neural network-based algorithms for rapid diagnosis and workflow optimization. Companies like Clarius Mobile Health and Ultrasound Workspace offer portable and advanced echocardiography solutions, while Vivid Ultra Edition and Echocardiography systems from GE Healthcare and Philips provide high-end, measurement uniformity, and heart function analysis. Technological developments continue to drive the market, with a focus on noninvasive diagnostic procedures, product innovation, and efficiency. Conditions such as uncontrolled hypertension, atrial fibrillation, and vaccination monitoring also contribute to the market's growth. Ultrasound systems like Ultrasound 3300 from General Imaging and Cardiovascular Imaging offer diagnostic test time reduction and improved diagnostic accuracy.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
End-user
Hospitals
Diagnostic Centers
Product
Resting
Ambulatory
Stress
Geography
North America
Europe
Asia
Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website:
SOURCE Technavio
